MRI and bladder marker planning to guide bladder chemoradiation
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses special MRI scans and tiny markers placed in the bladder to better plan bladder chemoradiation. The goal is to help target treatment more accurately and improve how well it can be delivered.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have bladder cancer confirmed by lab testing (biopsy or urine cell tests), mainly the usual bladder cancer type
- Your cancer is at stage T2 to T4a and has no distant spread, and you plan to get bladder chemoradiation
- You are scheduled for a TURBT procedure (a bladder scope to remove/biopsy tumor) before starting chemo radiation
- Your kidneys work well enough for treatment, and you can safely have MRI contrast (if needed)
- You can follow the contraception rules during the study and for 90 days after stopping treatment
- No prior or planned bladder radiation, and no bladder chemo or biologic treatment within 6 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI scan (mpMRI) to figure out how far suspected muscle-invasive bladder cancer has spread, using a new local staging approach. If the results are accurate, it may help doctors plan the most appropriate curative treatment sooner.
This trial tests a new type of radiation therapy that adjusts to your body's changes during treatment. It aims to reduce side effects and improve accuracy for people with bladder cancer.
This study looks at how bladder cancer is treated and what biological markers are present in patients in Russia. If you join, you may help doctors learn more about which treatments work best based on your tumor type.
This trial uses advanced MRI scanning to guide treatment decisions for muscle invasive bladder cancer. It aims to improve outcomes by personalizing therapy based on detailed imaging.
This early-stage study uses special MRI imaging to create a “virtual view” of the bladder wall so doctors can better stage bladder cancer before treatment. If you qualify, you may get MRI imaging using contrast medicines as part of planning your surgery.
This trial tests a new treatment approach using MRI to guide bladder preservation for patients with muscle-invasive bladder cancer. The goal is to treat the cancer with chemotherapy and radiation instead of removing the bladder, potentially allowing you to keep your bladder while fighting the cancer.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.